How does the ABPI Code apply to congresses?
How does the ABPI Code apply to congresses? Mitigating the risks of breaching the Code. The ABPI Code of Practice provides guidance for pharmaceutical industry...
Digitising the pharmaceutical supply chain
Marcelo Cruz, Head of Marketing and Business Development at Tjoapack, discusses whether digitisation can fundamentally change the way the pharmaceutical supply chain operates. Over the...
Pharma supply chain management and packaging in 2020
Rich Quelch, Global Head of Marketing at Origin, looks at what we can expect from pharma supply chain management and packaging in 2020? Considered by...
Key publications to impact the UK access environment in 2020
Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
Driving innovation in a modern NHS
The role of the Accelerated Access Collaborative and how it is driving innovation in a modern NHS is discussed by James Roach and Johnny...
Progress on human medicinal product standards in 2020
Frits Stulp, Managing Director of Iperion Life Sciences Consultancy, looks at how veterinary regulations disrupt progress on human medicinal product standards in 2020, and...
Harnessing academic excellence for biotech and drug discovery
Graeme Wilkinson, Head of Virtual R&D at Medicines Discovery Catapult, looks at how the UK can harness academic excellence to create the high quality...
Global outsourced pharma services market in 2020
Ramesh Jassal, Director and International Head of Healthcare at Clearwater International, analyses pricing pressure and how patent expiries will continue to drive strong growth...
Pharma in 2019: Has uncertainty led to pharma innovation and change?
As the year draws to a close, has uncertainty led to pharma innovation and change in 2019? Have we been in a Brexit-related stasis?...
Google or GP: Who Does the Public Trust More?
Ramya Sriram, Content and Communications Specialist at Kolabtree, looks how new research considers where the public goes for medical information and how they can...
Latest articles
Sanofi and Translate Bio collaborate on novel mRNA vaccine for COVID-19
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, will collaborate to develop a...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Chloroquine and Hydroxychloroquine not licensed for coronavirus treatment
The MHRA has released guidance saying that Chloroquine and Hydroxychloroquine are not licensed for coronavirus treatment. Recent media reports have suggested that chloroquine can protect...
Popular articles
NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Boost to COVID-19 vaccine and therapy research
COVID-19 vaccine and therapy research has been boosted by six new projects in rapid response. The six new studies into the novel coronavirus have...
New data on Symbicort as anti-inflammatory asthma reliever
New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...